Last reviewed · How we verify
Analgesics, Opioid
Opioid receptor agonist
Opioid receptor agonist Used for Pain management.
At a glance
| Generic name | Analgesics, Opioid |
|---|---|
| Also known as | Opioid Group |
| Sponsor | LinkCare GmbH |
| Drug class | Opioid analgesic |
| Target | Opioid receptors |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
Activates opioid receptors in the brain, leading to pain relief.
Approved indications
- Pain management
Common side effects
- Nausea
- Vomiting
- Constipation
Key clinical trials
- Comparison of Two Intravenous Drug Combinations for Ambulatory Oral & Maxillofacial Surgery (PHASE1)
- Management of Pain in Lumbar Arthrodesis (PHASE4)
- Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
- Compared Reversed US-Guided Dorsal Penile Nerve Block (RUSDPNB) With DPNB in Circumcisions for Pediatric Patients (NA)
- The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster (NA)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy (PHASE4)
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |